Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations. - Wikidata - wikimedia - TriplyDB

Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.

Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.

http://www.wikidata.org/entity/Q33396013

about

Current treatment of atypical hemolytic uremic syndrome Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease.Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.Eculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysis.

P2860

Q27003211-B28406D6-A2A2-43AE-ACB4-5CA1D26A1F2E Q33401403-D6B13CCE-492E-40F8-9B36-92B5EF6E3D6C Q33402385-32C4E4DC-A6D6-4EA8-A1B3-3CECF763B40F Q33402784-ECF3987E-9A16-49C6-A433-ECF01B49E78E Q33409030-BBB255C1-619D-42FE-A6B3-3E74B4CD1491 Q33439759-11E427BE-4395-4636-989C-8ECD4D6794F2 Q38082735-9C57D105-BA99-471B-B0A6-346DEA21164C Q38118112-8542EDCD-C9C0-4D83-BC30-9D4FC7E415E7 Q39718987-70F267F9-6ED3-434A-A480-391EA6887318

P2860

Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.

http://www.wikidata.org/entity/Q33396013

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Plasma therapy for atypical ha ...... terozygous factor H mutations.

@ast

Plasma therapy for atypical ha ...... terozygous factor H mutations.

@en

type

label

Plasma therapy for atypical ha ...... terozygous factor H mutations.

@ast

Plasma therapy for atypical ha ...... terozygous factor H mutations.

@en

prefLabel

Plasma therapy for atypical ha ...... terozygous factor H mutations.

@ast

Plasma therapy for atypical ha ...... terozygous factor H mutations.

@en

P1433

Q33396013-7BE345C6-1381-4916-8284-C7DEE9C54EC4

P1476

Q33396013-A1282332-856A-49D7-9E57-416A863DCBB7

P2093

Q33396013-2080ACB9-3129-4589-B440-0A550565EBDE

Q33396013-93D4DD0C-1372-4834-91EB-7F9E860676F7

Q33396013-BD0C1329-9FB3-46C8-984E-3D4013D1BF7F

Q33396013-BF687E2E-6B67-4387-9256-CE9F3DBED5C0

P2860

Q33396013-03288BD2-BAD9-4F08-8AE9-B00AD0889BEF

Q33396013-0B923BB1-66F2-4E10-B8EA-317CAADEE3FB

Q33396013-231BE764-8DDF-4605-9111-755926EACA30

Q33396013-2702111B-7CB4-46FE-AE45-B29A79342EB9

Q33396013-45AABB19-73AB-4B07-B92D-7A636C2C00FA

Q33396013-737DA1E9-07C3-4A03-9922-E9CF3E50F85A

Q33396013-797C0E93-8CD4-4CB7-A14B-E1AFC6C63B90

Q33396013-A30BCBEA-3970-4A70-B707-2BB9F7179A97

Q33396013-CE1C58BE-D23E-42A3-BA8A-66ACBCA0A413

Q33396013-D1C89BBC-1940-44A4-A115-7B1675CE58A2

P2888

Q33396013-BDB70C49-5724-41CD-9E10-BDD43AA11BBD

P304

Q33396013-4C1E5133-B5C0-4783-BE19-260544B4F107

P31

Q33396013-B2201F01-EAB3-4DD5-BF10-2FB714A82576

P356

Q33396013-A08841C1-36CC-449B-B744-2156542A1121

P433

Q33396013-BD695E81-905D-4999-8CD1-E421D3153E4A

P478

Q33396013-D6F7A05C-6B3D-4449-A20D-F3A7000C7581

P577

Q33396013-A156E60F-2946-4C32-90FC-EA11B611C606

P6179

Q33396013-D65C8414-31E7-4231-9D1E-404F3073CA23

P698

Q33396013-9803CC66-1AF3-443A-A348-5BA910CCAAE7

P356

S00467-011-1944-4

P1433

Pediatric Nephrology

P1476

Plasma therapy for atypical ha ...... terozygous factor H mutations.

@en

P2093

Carol Inward

http://www.w3.org/2001/XMLSchema#string

Jane Tizard

http://www.w3.org/2001/XMLSchema#string

Jon Jin Kim

http://www.w3.org/2001/XMLSchema#string

Tim H J Goodship

http://www.w3.org/2001/XMLSchema#string

P2860

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models

Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.

Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.

Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment.

Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations.

Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.

P2888

s00467-011-1944-4

P304

2073-2076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-011-1944-4

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043714820

http://www.w3.org/2001/XMLSchema#string

P698

21717289

http://www.w3.org/2001/XMLSchema#string